NIP7 inhibitors form a specialized group of chemical compounds designed to specifically target and decrease the activity of NIP7, a protein known to play a pivotal role in ribosomal RNA processing and the biogenesis of the 60S ribosomal subunit. These inhibitors work by directly interacting with the NIP7 protein, binding to critical domains necessary for its function, and effectively blocking its involvement in ribosome assembly. This inhibition can lead to a decrease in the efficiency of ribosome production, a process essential for protein synthesis within the cell. Alternatively, NIP7 inhibitors may act indirectly by interfering with the protein's interaction with other essential ribosomal biogenesis factors or by disrupting the cellular localization of NIP7, thereby impairing its function. The development of these inhibitors is driven by the goal of understanding the precise role of NIP7 in ribosomal assembly and its broader implications for cellular function and growth.
The discovery and characterization of NIP7 inhibitors involve a multi-faceted approach that encompasses both in silico and empirical methodologies. Initially, computational techniques such as molecular docking and virtual screening are employed to identify potential inhibitory compounds with a high affinity for NIP7. These candidates are then subjected to rigorous in vitro assays, including competitive binding assays and kinetic analyses, to validate their inhibitory effects on NIP7 activity. Following in vitro validation, cell-based assays are conducted to observe the impact of these inhibitors on cellular processes dependent on efficient ribosome biogenesis, such as protein synthesis rates, cell growth, and proliferation. Techniques such as quantitative PCR and Western blotting may be used to assess changes in the levels of ribosomal RNA and proteins, providing insights into the efficacy and mechanism of action of NIP7 inhibitors at a cellular level. Additionally, advanced imaging techniques, including fluorescence microscopy, can be utilized to examine alterations in nucleolar morphology, further elucidating the role of NIP7 in ribosome assembly. Through these comprehensive investigations, NIP7 inhibitors are explored not only for their potential to demystify the biological functions of NIP7 but also for their capacity to contribute to the broader understanding of ribosome biogenesis and its impact on cellular physiology.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates into DNA and inhibits RNA polymerase, which can indirectly affect NIP7's role in rRNA processing. | ||||||
CX-5461 | 1138549-36-6 | sc-507275 | 5 mg | $245.00 | ||
CX-5461 selectively inhibits RNA polymerase I, potentially impacting NIP7's function in ribosome biogenesis. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Mycophenolic Acid inhibits inosine monophosphate dehydrogenase, which can influence RNA processing and indirectly affect NIP7. | ||||||
BMH-21 | 896705-16-1 | sc-507460 | 10 mg | $165.00 | ||
BMH-21 binds to RNA polymerase I and disrupts ribosomal DNA transcription, potentially impacting NIP7 function. | ||||||
Thiostrepton | 1393-48-2 | sc-203412 sc-203412A | 1 g 5 g | $117.00 $423.00 | 10 | |
Thiostrepton inhibits both protein synthesis and rRNA processing, which might indirectly affect NIP7's role in ribosome biogenesis. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Fluorouracil interferes with nucleotide synthesis and can affect RNA processing, indirectly impacting NIP7. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $52.00 $125.00 $182.00 | 11 | |
Homoharringtonine inhibits protein synthesis by preventing the initial elongation step, which can indirectly affect NIP7's function. | ||||||
Ribavirin | 36791-04-5 | sc-203238 sc-203238A sc-203238B | 10 mg 100 mg 5 g | $63.00 $110.00 $214.00 | 1 | |
Ribavirin, an antiviral drug, can influence RNA metabolism and may indirectly impact NIP7. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a kinase involved in ribosome biogenesis, potentially affecting NIP7's role. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide inhibits eukaryotic protein synthesis, which could indirectly affect NIP7's function in ribosome biogenesis. | ||||||